It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

Christmas, Kwanzaa, and other end-of-year holidays typically mean travel followed by close indoor contact with friends or loved ones — near-perfect conditions for nasty airborne viruses to spread. And ...

Sanofi ( ($SNY) ) just unveiled an update. In December 2025, Sanofi announced the completion of its acquisition of Vicebio Ltd, which enhances its ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

GSK (GSK) stock is in focus as an expert panel of the European Medicines Agency ((EMA)) endorses the company's Arexvy RSV ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Last year's flu season between 2024-25 saw 542 flu-related deaths, which broke state records since record keeping began in ...

TikTok, X, and Instagram are flooded with videos about a mysterious “2025 throat virus” that’s making everyone sick. The ...

A Once Human side quest called Lost in Madness will have you tracking down a Cultist Treasure Chest with the use of a map. On this page of our guide, you can find details of how to start Lost in ...

Sanofi (NASDAQ:SNY) is one of the best pharma stocks to invest in. Sanofi (NASDAQ:SNY) was downgraded to Neutral from ...